Is Astrana Health Stock a Good Investment?
Astrana Health Investment Advice | ASTH |
- Examine Astrana Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Astrana Health's leadership team and their track record. Good management can help Astrana Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Astrana Health's business and its evolving consumer preferences.
- Compare Astrana Health's performance and market position to its competitors. Analyze how Astrana Health is positioned in terms of product offerings, innovation, and market share.
- Check if Astrana Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Astrana Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Astrana Health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Astrana Health is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Astrana Health Stock
Researching Astrana Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 25.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.96. Some equities with similar Price to Book (P/B) outperform the market in the long run. Astrana Health had not issued any dividends in recent years. The entity had 1:10 split on the 27th of April 2015.
To determine if Astrana Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Astrana Health's research are outlined below:
| Astrana Health generated a negative expected return over the last 90 days | |
| Astrana Health has high historical volatility and very poor performance | |
| About 25.0% of the company shares are held by company insiders |
Astrana Health's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.4 B.Astrana Health's profitablity analysis
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average.Determining Astrana Health's profitability involves analyzing its financial statements and using various financial metrics to determine if Astrana Health is a good buy. For example, gross profit margin measures Astrana Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Astrana Health's profitability and make more informed investment decisions.
Basic technical analysis of Astrana Stock
As of the 22nd of March, Astrana Health shows the Standard Deviation of 4.52, mean deviation of 2.6, and Risk Adjusted Performance of 0.004. Astrana Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Astrana Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Astrana Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Astrana Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Astrana Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Astrana Health's Outstanding Corporate Bonds
Astrana Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Astrana Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Astrana bonds can be classified according to their maturity, which is the date when Astrana Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US03765HAB78 Corp BondUS03765HAB78 | View | |
| US03765HAD35 Corp BondUS03765HAD35 | View | |
| US03765HAF82 Corp BondUS03765HAF82 | View | |
| US03762UAD72 Corp BondUS03762UAD72 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Apollo Investment 525 Corp BondUS03761UAG13 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Understand Astrana Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Astrana Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.004 | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 2.6 | |||
| Coefficient Of Variation | (22,181) | |||
| Standard Deviation | 4.52 | |||
| Variance | 20.41 | |||
| Information Ratio | 0.0082 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | 0.3128 | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 33.26 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 5.43 | |||
| Skewness | (3.46) | |||
| Kurtosis | 20.66 |
| Risk Adjusted Performance | 0.004 | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 2.6 | |||
| Coefficient Of Variation | (22,181) | |||
| Standard Deviation | 4.52 | |||
| Variance | 20.41 | |||
| Information Ratio | 0.0082 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | 0.3128 | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 33.26 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 5.43 | |||
| Skewness | (3.46) | |||
| Kurtosis | 20.66 |
Consider Astrana Health's intraday indicators
Astrana Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Astrana Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Astrana Health time-series forecasting models is one of many Astrana Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Astrana Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Astrana Stock media impact
Far too much social signal, news, headlines, and media speculation about Astrana Health that are available to investors today. That information is available publicly through Astrana media outlets and privately through word of mouth or via Astrana internal channels. However, regardless of the origin, that massive amount of Astrana data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Astrana Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Astrana Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Astrana Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Astrana Health alpha.
Astrana Health Corporate Management
| WaiChow MD | Chief Officer | Profile | |
| Rita Pew | Vice Operations | Profile | |
| Carlos MD | Chief Texas | Profile | |
| CPA CGMA | Chief Officer | Profile |
Already Invested in Astrana Health?
The danger of trading Astrana Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Astrana Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Astrana Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Astrana Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Astrana Health's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.